Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
about
Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway.MicroRNA-23b Inhibits the Proliferation and Migration of Heat-Denatured Fibroblasts by Targeting Smad3Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the WoundsTargeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-β1/Smad/CTGF signaling pathway.Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation.Current Therapeutic Approach to Hypertrophic Scars.Decorin reduces hypertrophic scarring through inhibition of the TGF-β1/Smad signaling pathway in a rat osteomyelitis modelAutophagy protein LC3 regulates the fibrosis of hypertrophic scar by controlling Bcl-xL in dermal fibroblasts.Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor.Physical Properties of Implanted Porous Bioscaffolds Regulate Skin Repair: Focusing on Mechanical and Structural Features.Loureirin B promotes insulin secretion through inhibition of KATP channel and influx of intracellular calcium.MicroRNA-222 regulates the viability of fibroblasts in hypertrophic scars via matrix metalloproteinase 1.Lower energy radial shock wave therapy improves characteristics of hypertrophic scar in a rabbit ear model.Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p
P2860
Q33575628-C7EC7B6E-B71B-4847-83A0-96CB690D3EE6Q35685793-347C3F28-58E6-40A3-928E-D973494595BBQ36864027-74052D64-B3E5-4FBE-95CE-880691BDC61FQ37454142-00C66802-5C18-475C-A08A-0DEA995F1859Q38769935-428D779E-5C2E-4773-B913-352E935ECDA2Q38970003-AC842984-EA78-4A06-A7DF-AA00038CEBF6Q39414298-07A59B4E-029F-4314-BBCE-1FBD8DBEBE19Q40518248-78DD8AE1-533A-4DC5-B5E3-BD05CE0022FCQ47137354-2997C545-A369-41D3-9A66-FFA851C7D176Q47168284-1618794B-2987-4018-B1A8-7EB6B7EE59E3Q47732113-D6D45C9A-7F32-417A-8474-6FD8A632C40CQ47940901-CCD5C69E-7531-4782-B877-8A04C125A4B5Q50054021-39FC009E-5ACE-4BB4-BF9B-478A2FFBBF6BQ50054263-9D6B1861-AC93-4A03-9E70-2F3F79FFC958Q58803095-5963293D-3C63-4273-A7A6-B3A90953EC9A
P2860
Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@en
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@nl
type
label
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@en
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@nl
prefLabel
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@en
Loureirin B inhibits fibroblas ...... c scar via TGF-β/Smad pathway.
@nl
P2093
P2860
P356
P1476
Loureirin B inhibits fibroblas ...... ic scar via TGF-β/Smad pathway
@en
P2093
Chaowu Tang
Jihong Shi
Xiaozhi Bai
Yunchuan Wang
P2860
P304
P356
10.1111/EXD.12665
P50
P577
2015-03-09T00:00:00Z